Diseases from the Spectrum of Dermatitis and Eczema: Can “Omics” Sciences Help with Better Systematics and More Accurate Differential Diagnosis?

Abstract

Researchers active in the field of inflammatory skin diseases from the spectrum of dermatitis and eczema are well aware of a considerable overlap in the clinical pictures and proposed sets of diagnostic criteria for these diseases, which can hardly be overcome through the clinical or epidemiological research. In effect, patients are included in studies based on vague and overlapping criteria, while heterogeneous study populations may, in turn, lead to non-representative outcomes and continued confusion. In this narrative review, a systematics of diseases from the spectrum of dermatitis and eczema is proposed based on the origins of causative factors and the pathomechanisms involved. Difficulties in differentiating between these diseases are discussed, and the extent to which advances in the “omics” sciences might help to overcome them is considered. Of all the “omics” research in this field, more than 90% of the published papers were devoted to atopic dermatitis, with a striking underrepresentation of other diseases from the spectrum of dermatitis and eczema, conditions which collectively exceed the rates of atopic dermatitis by far. A greater “omics” research effort is urgently needed to tackle other dermatitides, like allergic, irritant and protein contact dermatitis, as well as radiation, seborrheic, stasis or autoimmune dermatitis. Atopic dermatitis findings should be validated not only against healthy donors but also other dermatitides. A clinic-oriented approach is proposed for future “omics” studies in the field of dermatitis and eczema.

Discovery of biomarkers in the psoriasis through machine learning and dynamic immune infiltration in three types of skin lesions

“…The correct diagnosis of these two diseases involves the correct selection and use of biologics, and the correct and effective use of biologics can realize its true treatment meaning ( 8 , 9 ). Thus, for mixed patients or PsO patients whose lesions are difficult to distinguish from AD patients, more accurate diagnostic markers are needed to carry out differential diagnosis ( 10 ).…”

Atopy and allergic diseases among college students at a Saudi Public University

“…Both allergen exposure, which results in the development of specific IgE antibodies, and additional realization factors are necessary for the appearance of an atopic condition. [ 4 5 ] Asthma is undoubtedly the most dangerous allergy condition because it may be both lethal and disabling, accounting for more than 100,000 hospital admissions annually in England and Wales. One hundred thirty-seven persons under 45 died from asthma-related causes in 1995.…”